Stocks · News reference

8-K filing — COGNITION THERAPEUTICS INC (CGTX)

Jun 24, 2026, 11:39 AMSEC EDGAR

Filed: 2026-06-24 AccNo: 0001104659-26-077060 Size: 218 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: edgar
Observed: Jun 24, 2026, 11:39 AM
Checked: Jun 24, 2026, 11:39 AM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 6, 2026, 9:13 PMBenzinga Newsdesk
Cognition Therapeutics Q2 EPS $(0.04) Beats $(0.06) Estimate
Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 63.64 percent increase over losses of $(0.11) per
Read original at benzinga
CGTX
BenzingaJun 24, 2026, 11:39 AMBenzinga Newsdesk
FDA Agrees Psychosis Associated With Dementia With Lewy Bodies May Be Approvable Outcome, Reaches Alignment With Cognition Therapeutics On Vital Aspects To Support Its New Drug Application
Read original at benzinga
CGTX
BenzingaJun 16, 2026, 11:32 AMBenzinga Newsdesk
Cognition Therapeutics Receives Notice Of Allowance From USPTO For Patent Application 19/563,468, Covering Polymorphic Crystalline Form Of Zervimesine
Read original at benzinga
CGTX